Looking to publish in Multiple Sclerosis and Related Disorders? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowMultiple Sclerosis and Related Disorders is a comprehensive journal dedicated to advancing the understanding, diagnosis and treatment of multiple sclerosis and related immune-mediated and infectious diseases of the central nervous system. Its scope includes clinical neurology, neuroepidemiology, neurobiology, neuroimaging, neuroimmunology, genetics, biomarkers, neuropsychology, neurorehabilitation, and novel therapeutics, and it welcomes Original Research, Reviews, Clinical Trials, Letters to the Editors, Editorials, and Commentaries.
Looking to publish in Multiple Sclerosis and Related Disorders? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Multiple Sclerosis and Related Disorders accepts the following article types. Click on an article type to view submission instructions.
Original Research
Reviews
Clinical Trials
Full Length Research Papers
Letters To The Editors
Recent Publications
Association of somatosensory evoked potentials with cervical spinal cord atrophy and disability progression in multiple sclerosis
Cansu Köseoğlu Toksoy, Taha Burak Ayaz, Ahmed Serkan Emekli, Tuncay Gündüz, Murat Kürtüncü
A Pre-symptomatic phase of tumefactive multiple sclerosis mirrors radiologically isolated syndrome
Albert Aboseif, Nur Neyal, B. Mark Keegan, Jeanette E. Eckel-Passow, Aksel Siva, Christine Lebrun-Frenay, Darin T. Okuda, W. Oliver Tobin, Burcu Zeydan, Orhun H. Kantarci
Immunotherapy decision coaching for people with multiple sclerosis – Implementation of an interprofessional decision support programme into clinical practice
NC Wiechel, A Schneider, J Peper, K Grentzenberg, S Lau, N Krause, AC Rahn, C Heesen
The effects of smoking and vaping on multiple sclerosis onset and disease progression: an umbrella review
Alex Maximilian Keller, Olivia Wills, Amalia Karahalios, Claudia H. Marck
Exploratory Analysis of Pupillography-Based Machine Learning for Assessing Autonomic Dysfunction in Multiple Sclerosis
Neslihan Parmak Yener, Yelda Fırat, Meral Seferoğlu, Ahmet Metin Kargın, Yılmaz Kılıçaslan
Frequently asked questions
How long does it take to publish?
4 days submission to first decision; 54 days submission to decision after review; 115 days submission to acceptance; 2 days acceptance to online publication.
Reformat to Multiple Sclerosis and Related Disorders using Livewrite PremiumWhat are the publication costs?
Open access APC: USD 3450 excluding taxes. Subscription publication has no open access publication fee.
Reformat to Multiple Sclerosis and Related Disorders using Livewrite Premium